99mTc-Rebmab200

N/A

Report date: 2025/11/11 17:59:28

Base Information

Drug Name99mTc-Rebmab200

Drug Alias Name99mTc-Rebmab200

ClassificationRadiation-emitting products > Nuclides > Technetium > 99mTcRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-Sodium-dependent phosphate transport protein 2B

TargetsSodium-dependent phosphate transport protein 2B

Therapy Area/IndicationsCarcinoma, Ovarian Epithelial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBrazil

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRecepta Biopharma Sa

China Registration ClassN/A

Develop Information

Active CompaniesRecepta Biopharma Sa

Inactive CompaniesN/A

Active IndicationsCarcinoma, Ovarian Epithelial

Inactive IndicationsN/A

Other Information

ATC CodeN/A